OTCMKTS:ABMC American Bio Medica (ABMC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC Filings About American Bio Medica Stock (OTCMKTS:ABMC) Get American Bio Medica alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview American Bio Medica Corporation is a diagnostic-products company focused primarily on tests used to detect drugs of abuse. Its products are designed to provide rapid, on-site screening results without requiring immediate laboratory processing. The company has marketed urine- and oral-fluid-based testing products for use by employers, law-enforcement agencies, correctional facilities, schools, healthcare organizations and other institutions. Its offerings have included multi-drug screening kits and related collection or testing products. American Bio Medica has historically operated from the United States and has served domestic and international customers through distributors and direct sales channels. Publicly available information about its current operations, leadership and geographic reach is limited, so additional details could not be confirmed reliably.AI Generated. May Contain Errors. Read More Receive ABMC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for American Bio Medica and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ABMC Stock News HeadlinesAmerican Bio Medica Corp. (ABMC)April 17, 2026 | nasdaq.comAmerican Bio Medica CorpApril 19, 2024 | morningstar.comMINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and built in a matter of weeks. James Altucher says the site could go live as soon as October 21 and has put together a free presentation explaining what is happening inside and why the timing matters.October 16 at 1:00 AM | Paradigm Press (Ad)Oxford Biomedica Solutions to Present Company Capabilities and its Platform at American Society of Gene and Cell Therapy in Los AngelesMay 9, 2023 | technews.tmcnet.comSpecimen Validity Testing Market 2023 with Regional Segmentations Forecast till 2030May 4, 2023 | marketwatch.comSpecimen Validity Testing Market Research, 2023-2030April 27, 2023 | marketwatch.comABMC American Bio Medica CorporationApril 27, 2023 | seekingalpha.comAmerican Bio Medica sells headquarters as part of asset sale to Healgen ScientificMarch 14, 2023 | bizjournals.comSee More Headlines ABMC Stock Analysis - Frequently Asked Questions How were American Bio Medica's earnings last quarter? American Bio Medica Corp. (OTCMKTS:ABMC) released its quarterly earnings data on Monday, May, 14th. The company reported ($0.01) EPS for the quarter. The company had revenue of $1.04 million for the quarter. What other stocks do shareholders of American Bio Medica own? Based on aggregate information from My MarketBeat watchlists, some other companies that American Bio Medica investors own include Adobe (ADBE), AGNC Investment (AGNC), REX AI Equity Premium Income ETF (AIPI), Ares Capital (ARCC), Arrowhead Pharmaceuticals (ARWR), Alcoa (AA) and Arbor Realty Trust (ABR). Company Calendar Last Earnings5/14/2018Today10/16/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:ABMC CIK896747 Webwww.abmc.com Phone(518) 758-8158Fax518-758-8171Employees30Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (OTCMKTS:ABMC) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding American Bio Medica Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share American Bio Medica With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
